Full Press Release Details
InfuSystem Holdings, Inc.
Post Shareholders Meeting
Jonathan P. Foster, CFO
INFUSION MADE EASY SM
Safe Harbor Statement
contained in this release are forward-looking statements and are based on future expectations, plans and prospects for InfuSystem Holdings, Inc. s ( InfuSystem , INFU , the Company , We ) business and
operations that involve a number of risks and uncertainties. InfuSystem s outlook for 2013 and other forward-looking statements in this release are made as of August 29, 2013, and the Company disclaims any duty to supplement, update or
revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise. In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995,
the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, potential
changes in overall healthcare reimbursement - including CMS competitive bidding, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of
chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions & joint ventures, US Healthcare Reform, relationships with
healthcare professionals and organizations, technological changes related to infusion therapy, dependency on websites and intellectual property, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel,
dependency on banking relations and covenants, and other risks associated with our common stock, as well as any other litigation to which the Company may be subject from time to time; and other risk factors as discussed in the Company s annual
10-K for the year ended December 31, 2012 and in other filings made by the Company from
time to time with the Securities and Exchange Commission.
INFUSION MADE EASY SM
Positioned for Growth
INFUSION MADE EASY SM
Positioned For Growth
InfuSystem is uniquely positioned to take advantage of market trends
Transformational strategy is developed and being implemented
Leadership can now focus on running a
business for first time in over a year
INFUSION MADE EASY SM
InfuSystem Patient Population is Extension of Infusion Therapy From Clinic to Home
INFUSION MADE EASY SM
Extension of Clinic to Home
Some drugs more effective when infused continuously
Patient Satisfaction
Multiple Therapies - Oncology, Post Surgical Pain, Special Disease States
Over 250 Payor Contracts
Private Pay & Government
Commercial Payors reimburse more therapies than CMS
INFUSION MADE EASY SM
Population Growth, Age and Growth of Cancers
At-risk lifestyles persist (red,
3rd most common in US and Worldwide
INFUSION MADE EASY SM
Infu Oncology Patients
* A.D.A.M. Medical Encyclopedia
Eat a lot of red or processed meats
Have a family history of colon cancer
Have a personal history of breast cancer
INFUSION MADE EASY SM
InfuSystem Cancer Patients
InfuSystem Patient Statistics
INFUSION MADE EASY SM
Rentals - Colorectal Cancer Rentals - Pain Management Sales - DP
Rentals - Other Cancers Rentals - Hospitals/Home Care
Rentals - Infectious Disease Rentals - Service & Repair
Rentals - Colorectal Cancer Rentals - Pain Management Sales - DP
Rentals - Other Cancers Rentals - Hospitals/Home Care
Rentals - Infectious Disease Rentals - Service & Repair
Increasing Therapy Offerings to Payors
Special Disease States
INFUSION MADE EASY SM
Continuous Peripheral Nerve Block at Home
are 5.69M orthopedic surgeries annual.
~50% of these patients are potential candidates for pain management with
a continuous peripheral nerve block (CPNB) Growth of CPNB
Growth of CPNB at Home
HCAHPS (H CAPS): Pain Scores affect Hospital Reimbursement.
INFUSION MADE EASY SM
Total Home Infusion Market
Home Infusion Market
Lower cost than clinical setting
Increasing Importance to lower cost in Affordable Care Act future
Lowest cost and highest patient satisfaction site for extension of infusion therapy is the home
Therapy started in a clinic
InfuSystem has 10 % of total and leading share of Oncology with 1,600 practice sites
INFUSION MADE EASY SM
Biomedical Rentals, Service and Repair
Rentals, Asset Management and Sales
Direct Sales of Device and Supplies
Pump Broker - ability to acquire CAP EX in cost effective way
Asset Management, Rental and Lease
Preventative Maintenance
ISO Certified Service Facilities -
Recertification just passed !
Regional Distribution
28 Certified Technicians
INFUSION MADE EASY SM
Offering Infusion to All Points of Care
INFUSION MADE EASY SM
Full Line Multi-Therapy & Multi-Point Offering
INFUSION MADE EASY SM
Device & Pharma Manufacturer, Distributor, GPO, ACO
INFUSION MADE EASY SM
What a Difference a Year Makes
IT improvements begun
New Product launches - Kits,
Smart Pumps, Post Surgical Pain
INFUSION MADE EASY SM
Shift into High Gear
More insurance billings with existing staff
Greater revenue per employee
Road Map completed , New iPad features, Automation of initial internal processes
INFUSION MADE EASY SM
Connectivity through eMAR , Web Portal and System Interface
Bring the Pumps to the People in Large Markets